Chester County News and Community Website
WILMINGTON, DE — AstraZeneca said new Phase III cancer and rare disease data presented at the American Society of Clinical Oncology annual meeting could strengthen the company’s position in several …
AstraZeneca Highlights Late-Stage Cancer, Rare Disease Data at ASCO Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) is expanding its partnership with biotechnology software firm Genesis Molecular AI in a deal worth $120 million upfront, giving the company broader access to …
Incyte Deepens AI Drug Discovery Bet in $120 Million Deal Read More
WILMINGTON, DE — The LYCRA Company emerged from Chapter 11 bankruptcy protection on May 20 after eliminating more than $1.2 billion in long-term debt and securing over $75 million in …
LYCRA Cuts Debt by $1.2 Billion, Exits Bankruptcy Protection Read More
WILMINGTON, DE — Financial services firms are facing mounting challenges managing executive compensation programs as participation expands, regulatory scrutiny increases and legacy technology systems struggle to handle growing administrative demands, …
Financial Firms Struggle to Manage Expanding Pay Programs Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) has entered a strategic collaboration with Edison Scientific to integrate an artificial intelligence platform across portions of its drug discovery and development operations, reflecting …
Incyte Expands AI Role in Drug Discovery Read More
WILMINGTON, DE — AstraZeneca received U.S. regulatory approval for BAXFENDY (baxdrostat), a new treatment for adults with uncontrolled hypertension, marking the first new drug class for the condition in years …
FDA Clears AstraZeneca Blood Pressure Drug, Expanding Options for Uncontrolled Hypertension Read More
WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) signed a new Internet of Things patent licensing agreement with an unnamed fintech company, extending the company’s monetization strategy beyond smartphones into connected …
InterDigital Expands IoT Licensing With Fintech Deal Read More
WILMINGTON, DE — Global Indemnity Group, LLC (Nasdaq: GBLI) appointed technology investor and healthcare venture executive Michele Colucci to its board of directors, which became effective May 18, as insurers …
Global Indemnity Adds Venture Capital Executive to Board Read More
WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO) signed exclusive letters of intent to acquire four online businesses with a combined $4.1 million in trailing adjusted EBITDA, a move the …
Onfolio Targets Acquisitions to Reach Positive Cash Flow Read More
WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) moved closer to potential commercialization of its preservative-free ketamine product in the first quarter as the company scaled manufacturing, advanced multiple FDA …
NRx Pushes Toward Ketamine Launch Amid FDA Review Read More